|
|
1 - Blood group Immunology English.vtt
|
VTT
|
3 KB
|
|
|
1 - Blood group Immunology.mp4
|
MP4
|
5.6 MB
|
|
|
10 - Immune Cell Recognition English.vtt
|
VTT
|
2.9 KB
|
|
|
10 - Immune Cell Recognition.mp4
|
MP4
|
6.9 MB
|
|
|
100 - Vasovagal Syncope vs Anaphylaxis English.vtt
|
VTT
|
9.9 KB
|
|
|
100 - Vasovagal Syncope vs Anaphylaxis.mp4
|
MP4
|
18.2 MB
|
|
|
101 - Corticosteroids Adverse Reactions English.vtt
|
VTT
|
4.2 KB
|
|
|
101 - Corticosteroids Adverse Reactions.mp4
|
MP4
|
8.8 MB
|
|
|
11 - T Cell Differentiation English.vtt
|
VTT
|
3.2 KB
|
|
|
11 - T Cell Differentiation.mp4
|
MP4
|
5.8 MB
|
|
|
12 - T Cell Maturation English.vtt
|
VTT
|
3.6 KB
|
|
|
12 - T Cell Maturation.mp4
|
MP4
|
6.9 MB
|
|
|
13 - T Cell Subsets English.vtt
|
VTT
|
2.8 KB
|
|
|
13 - T Cell Subsets.mp4
|
MP4
|
8.3 MB
|
|
|
14 - Th1 and Th2 Differentiation English.vtt
|
VTT
|
5.5 KB
|
|
|
14 - Th1 and Th2 Differentiation.mp4
|
MP4
|
13.3 MB
|
|
|
15 - FoxP3 and Tregs in IPEX English.vtt
|
VTT
|
5.5 KB
|
|
|
15 - FoxP3 and Tregs in IPEX.mp4
|
MP4
|
13.3 MB
|
|
|
16 - Tregs Regulation English.vtt
|
VTT
|
6 KB
|
|
|
16 - Tregs Regulation.mp4
|
MP4
|
14.2 MB
|
|
|
17 - ADA Inhibition English.vtt
|
VTT
|
5.5 KB
|
|
|
17 - ADA Inhibition.mp4
|
MP4
|
10.9 MB
|
|
|
18 - CGD Chronic Granulomatous Disease Overview Treatment English.vtt
|
VTT
|
4.1 KB
|
|
|
18 - CGD Chronic Granulomatous Disease Overview Treatment.mp4
|
MP4
|
7.7 MB
|
|
|
19 - Complement Deficiencies English.vtt
|
VTT
|
5.5 KB
|
|
|
19 - Complement Deficiencies.mp4
|
MP4
|
13 MB
|
|
|
2 - Immune response mechanism English.vtt
|
VTT
|
4.1 KB
|
|
|
2 - Immune response mechanism.mp4
|
MP4
|
11.3 MB
|
|
|
20 - HyperIgE Syndrome English.vtt
|
VTT
|
5.4 KB
|
|
|
20 - HyperIgE Syndrome.mp4
|
MP4
|
10.3 MB
|
|
|
21 - HyperIgM Syndrome English.vtt
|
VTT
|
5.1 KB
|
|
|
21 - HyperIgM Syndrome.mp4
|
MP4
|
10.4 MB
|
|
|
22 - Immunodeficiency Disorders English.vtt
|
VTT
|
5.7 KB
|
|
|
22 - Immunodeficiency Disorders.mp4
|
MP4
|
12 MB
|
|
|
23 - SCID Severe Combined Immunodeficiency Overview English.vtt
|
VTT
|
4.1 KB
|
|
|
23 - SCID Severe Combined Immunodeficiency Overview.mp4
|
MP4
|
6.4 MB
|
|
|
24 - WAS WiskottAldrich Syndrome Characteristics English.vtt
|
VTT
|
6.1 KB
|
|
|
24 - WAS WiskottAldrich Syndrome Characteristics.mp4
|
MP4
|
14.3 MB
|
|
|
25 - XLA Xlinked Agammaglobulinemia Immunodeficiency English.vtt
|
VTT
|
5.2 KB
|
|
|
25 - XLA Xlinked Agammaglobulinemia Immunodeficiency.mp4
|
MP4
|
12.2 MB
|
|
|
26 - XLA Xlinked Agammaglobulinemia Pathophysiology English.vtt
|
VTT
|
4.9 KB
|
|
|
26 - XLA Xlinked Agammaglobulinemia Pathophysiology.mp4
|
MP4
|
10.4 MB
|
|
|
27 - Hypersensitivity English.vtt
|
VTT
|
4.3 KB
|
|
|
27 - Hypersensitivity.mp4
|
MP4
|
9.6 MB
|
|
|
28 - Anaphylaxis Symptoms and Treatment English.vtt
|
VTT
|
3.7 KB
|
|
|
28 - Anaphylaxis Symptoms and Treatment.mp4
|
MP4
|
7.4 MB
|
|
|
29 - Angioedema Causes English.vtt
|
VTT
|
5 KB
|
|
|
29 - Angioedema Causes.mp4
|
MP4
|
6.2 MB
|
|
|
3 - Enhance immune response.mp4
|
MP4
|
8.8 MB
|
|
|
30 - Latex Allergy English.vtt
|
VTT
|
3.7 KB
|
|
|
30 - Latex Allergy.mp4
|
MP4
|
8.3 MB
|
|
|
31 - Latex Allergy Th2 Response English.vtt
|
VTT
|
3.2 KB
|
|
|
31 - Latex Allergy Th2 Response.mp4
|
MP4
|
6.4 MB
|
|
|
32 - Type I Allergy Pathophysiology English.vtt
|
VTT
|
4.3 KB
|
|
|
32 - Type I Allergy Pathophysiology.mp4
|
MP4
|
9.7 MB
|
|
|
33 - Atopic Dermatitis English.vtt
|
VTT
|
4.6 KB
|
|
|
33 - Atopic Dermatitis.mp4
|
MP4
|
9.5 MB
|
|
|
34 - Antivenom English.vtt
|
VTT
|
4.1 KB
|
|
|
34 - Antivenom.mp4
|
MP4
|
9.5 MB
|
|
|
35 - Cancer Immunotherapy English.vtt
|
VTT
|
3.3 KB
|
|
|
35 - Cancer Immunotherapy.mp4
|
MP4
|
5.1 MB
|
|
|
36 - Cancer immunotherapy PD 1 PD L1 English.vtt
|
VTT
|
3.9 KB
|
|
|
36 - Cancer immunotherapy PD 1 PD L1.mp4
|
MP4
|
8.2 MB
|
|
|
37 - Conjugate Vaccines English.vtt
|
VTT
|
3.5 KB
|
|
|
37 - Conjugate Vaccines.mp4
|
MP4
|
5.8 MB
|
|
|
38 - Hib Vaccines English.vtt
|
VTT
|
3 KB
|
|
|
38 - Hib Vaccines.mp4
|
MP4
|
7 MB
|
|
|
39 - Immunotherapy Fragment Options English.vtt
|
VTT
|
3.7 KB
|
|
|
39 - Immunotherapy Fragment Options.mp4
|
MP4
|
7.4 MB
|
|
|
4 - Immune Response Insights English.vtt
|
VTT
|
2.9 KB
|
|
|
4 - Immune Response Insights.mp4
|
MP4
|
6.8 MB
|
|
|
40 - Rituximab English.vtt
|
VTT
|
3.9 KB
|
|
|
40 - Rituximab.mp4
|
MP4
|
6.7 MB
|
|
|
41 - Treatment for GPA Granulomatosis with Polyangiitis English.vtt
|
VTT
|
3.6 KB
|
|
|
41 - Treatment for GPA Granulomatosis with Polyangiitis.mp4
|
MP4
|
5.8 MB
|
|
|
42 - Glucocorticoids in Allergy English.vtt
|
VTT
|
4.6 KB
|
|
|
42 - Glucocorticoids in Allergy.mp4
|
MP4
|
9.4 MB
|
|
|
43 - Glucocorticoids Antiinflammation English.vtt
|
VTT
|
4.8 KB
|
|
|
43 - Glucocorticoids Antiinflammation.mp4
|
MP4
|
11.6 MB
|
|
|
44 - Hyperacute Rejection English.vtt
|
VTT
|
4.1 KB
|
|
|
44 - Hyperacute Rejection.mp4
|
MP4
|
8.4 MB
|
|
|
45 - Transplant Rejection English.vtt
|
VTT
|
3.7 KB
|
|
|
45 - Transplant Rejection.mp4
|
MP4
|
8.4 MB
|
|
|
46 - Lung Transplant Rejection English.vtt
|
VTT
|
4.2 KB
|
|
|
46 - Lung Transplant Rejection.mp4
|
MP4
|
9 MB
|
|
|
47 - Lung Transplant Rejection continued English.vtt
|
VTT
|
3.5 KB
|
|
|
47 - Lung Transplant Rejection continued.mp4
|
MP4
|
8.4 MB
|
|
|
48 - Immunosuppressive Drugs English.vtt
|
VTT
|
3.4 KB
|
|
|
48 - Immunosuppressive Drugs.mp4
|
MP4
|
9 MB
|
|
|
49 - Immunosuppressive Drugs continued English.vtt
|
VTT
|
4.4 KB
|
|
|
49 - Immunosuppressive Drugs continued.mp4
|
MP4
|
8.5 MB
|
|
|
5 - Immunology Markers English.vtt
|
VTT
|
3.8 KB
|
|
|
5 - Immunology Markers.mp4
|
MP4
|
6.7 MB
|
|
|
50 - GVHD GraftVersusHost Disease Pathophysiology English.vtt
|
VTT
|
3.7 KB
|
|
|
50 - GVHD GraftVersusHost Disease Pathophysiology.mp4
|
MP4
|
8.5 MB
|
|
|
51 - Defense Against Pathogens English.vtt
|
VTT
|
4.2 KB
|
|
|
51 - Defense Against Pathogens.mp4
|
MP4
|
9.5 MB
|
|
|
52 - Eosinophils Kill Parasite English.vtt
|
VTT
|
3.1 KB
|
|
|
52 - Eosinophils Kill Parasite.mp4
|
MP4
|
6.2 MB
|
|
|
53 - Eosinophils English.vtt
|
VTT
|
3.1 KB
|
|
|
53 - Eosinophils.mp4
|
MP4
|
4.6 MB
|
|
|
54 - Effusions in Bacterial Pneumonia English.vtt
|
VTT
|
5.4 KB
|
|
|
54 - Effusions in Bacterial Pneumonia.mp4
|
MP4
|
11.1 MB
|
|
|
55 - Meningitis Capsules English.vtt
|
VTT
|
4.8 KB
|
|
|
55 - Meningitis Capsules.mp4
|
MP4
|
11 MB
|
|
|
56 - Differentiation and IL12 English.vtt
|
VTT
|
3.1 KB
|
|
|
56 - Differentiation and IL12.mp4
|
MP4
|
7.8 MB
|
|
|
57 - IFN Pathway in Immunity English.vtt
|
VTT
|
4.2 KB
|
|
|
57 - IFN Pathway in Immunity.mp4
|
MP4
|
8.3 MB
|
|
|
58 - Interferon Gamma Release English.vtt
|
VTT
|
3.9 KB
|
|
|
58 - Interferon Gamma Release.mp4
|
MP4
|
7.4 MB
|
|
|
59 - Interferons in Antiviral Action English.vtt
|
VTT
|
3.9 KB
|
|
|
59 - Interferons in Antiviral Action.mp4
|
MP4
|
8.4 MB
|
|
|
6 - Antibody Types English.vtt
|
VTT
|
4 KB
|
|
|
6 - Antibody Types.mp4
|
MP4
|
6.7 MB
|
|
|
60 - Interferons Antiviral Defense Activation English.vtt
|
VTT
|
4.3 KB
|
|
|
60 - Interferons Antiviral Defense Activation.mp4
|
MP4
|
10.5 MB
|
|
|
61 - Sepsis Cytokine English.vtt
|
VTT
|
4 KB
|
|
|
61 - Sepsis Cytokine.mp4
|
MP4
|
8.3 MB
|
|
|
62 - Vaccine Reactions English.vtt
|
VTT
|
5 KB
|
|
|
62 - Vaccine Reactions.mp4
|
MP4
|
10.5 MB
|
|
|
63 - Vaccine Impact on Aging and Immune System English.vtt
|
VTT
|
3.5 KB
|
|
|
63 - Vaccine Impact on Aging and Immune System.mp4
|
MP4
|
7.7 MB
|
|
|
64 - FasFasL in Autoimmunity English.vtt
|
VTT
|
3 KB
|
|
|
64 - FasFasL in Autoimmunity.mp4
|
MP4
|
6.8 MB
|
|
|
65 - Morbilliform Drug Eruption Explanation English.vtt
|
VTT
|
3.5 KB
|
|
|
65 - Morbilliform Drug Eruption Explanation.mp4
|
MP4
|
7.3 MB
|
|
|
66 - Urushiol Contact Dermatitis Mechanism English.vtt
|
VTT
|
4 KB
|
|
|
66 - Urushiol Contact Dermatitis Mechanism.mp4
|
MP4
|
8.4 MB
|
|
|
67 - SLE Systemic Lupus Erythematosus Manifestations English.vtt
|
VTT
|
2.5 KB
|
|
|
67 - SLE Systemic Lupus Erythematosus Manifestations.mp4
|
MP4
|
5.3 MB
|
|
|
68 - SLE Hematology English.vtt
|
VTT
|
4.5 KB
|
|
|
68 - SLE Hematology.mp4
|
MP4
|
9.4 MB
|
|
|
69 - Flow Cytometry English.vtt
|
VTT
|
2.1 KB
|
|
|
69 - Flow Cytometry.mp4
|
MP4
|
5 MB
|
|
|
7 - IgG Antibody Structure English.vtt
|
VTT
|
3.2 KB
|
|
|
7 - IgG Antibody Structure.mp4
|
MP4
|
6.3 MB
|
|
|
70 - Proteins and Immune Response English.vtt
|
VTT
|
5.9 KB
|
|
|
70 - Proteins and Immune Response.mp4
|
MP4
|
11.3 MB
|
|
|
71 - Radioimmunoassay RIA Fundamentals English.vtt
|
VTT
|
3.2 KB
|
|
|
71 - Radioimmunoassay RIA Fundamentals.mp4
|
MP4
|
6.8 MB
|
|
|
72 - Skin Testing English.vtt
|
VTT
|
2.6 KB
|
|
|
72 - Skin Testing.mp4
|
MP4
|
5.7 MB
|
|
|
73 - Abatacept Inhibits Tcell Activation English.vtt
|
VTT
|
4.2 KB
|
|
|
73 - Abatacept Inhibits Tcell Activation.mp4
|
MP4
|
7.6 MB
|
|
|
74 - Abatacept Mechanism in T Cells English.vtt
|
VTT
|
4.6 KB
|
|
|
74 - Abatacept Mechanism in T Cells.mp4
|
MP4
|
11.6 MB
|
|
|
75 - Arachidonic Acid Pathways Overview English.vtt
|
VTT
|
3.8 KB
|
|
|
75 - Arachidonic Acid Pathways Overview.mp4
|
MP4
|
6 MB
|
|
|
76 - Biological Agent Nomenclature English.vtt
|
VTT
|
3.3 KB
|
|
|
76 - Biological Agent Nomenclature.mp4
|
MP4
|
6.9 MB
|
|
|
77 - Class I MHC Pathway English.vtt
|
VTT
|
3 KB
|
|
|
77 - Class I MHC Pathway.mp4
|
MP4
|
5.9 MB
|
|
|
78 - Contact Dermatitis Type IV English.vtt
|
VTT
|
4.6 KB
|
|
|
78 - Contact Dermatitis Type IV.mp4
|
MP4
|
8.6 MB
|
|
|
79 - Endogenous Antigen Processing MHC English.vtt
|
VTT
|
3.9 KB
|
|
|
79 - Endogenous Antigen Processing MHC.mp4
|
MP4
|
9.6 MB
|
|
|
8 - Opsonins English.vtt
|
VTT
|
3.1 KB
|
|
|
8 - Opsonins.mp4
|
MP4
|
5.1 MB
|
|
|
80 - Etanercept Mechanism Explained English.vtt
|
VTT
|
4.7 KB
|
|
|
80 - Etanercept Mechanism Explained.mp4
|
MP4
|
11.5 MB
|
|
|
81 - Extrinsic Pathway of Apoptosis English.vtt
|
VTT
|
3.1 KB
|
|
|
81 - Extrinsic Pathway of Apoptosis.mp4
|
MP4
|
6.4 MB
|
|
|
82 - IgA Transcytosis Process Explanation English.vtt
|
VTT
|
4.9 KB
|
|
|
82 - IgA Transcytosis Process Explanation.mp4
|
MP4
|
12 MB
|
|
|
83 - IgG Function and Structure English.vtt
|
VTT
|
4.9 KB
|
|
|
83 - IgG Function and Structure.mp4
|
MP4
|
10.8 MB
|
|
|
84 - IgG Structure and Function English.vtt
|
VTT
|
4.4 KB
|
|
|
84 - IgG Structure and Function.mp4
|
MP4
|
8 MB
|
|
|
85 - Immunoglobulin Classes Explained English.vtt
|
VTT
|
4.2 KB
|
|
|
85 - Immunoglobulin Classes Explained.mp4
|
MP4
|
9.3 MB
|
|
|
86 - MHC Class I vs II English.vtt
|
VTT
|
4.7 KB
|
|
|
86 - MHC Class I vs II.mp4
|
MP4
|
11.4 MB
|
|
|
87 - MHC Deficiency Diagnosis English.vtt
|
VTT
|
4.1 KB
|
|
|
87 - MHC Deficiency Diagnosis.mp4
|
MP4
|
9 MB
|
|
|
88 - MHC Pathways Explained English.vtt
|
VTT
|
3.6 KB
|
|
|
88 - MHC Pathways Explained.mp4
|
MP4
|
6.4 MB
|
|
|
89 - NK Cells Function and Recognition English.vtt
|
VTT
|
2.4 KB
|
|
|
89 - NK Cells Function and Recognition.mp4
|
MP4
|
5 MB
|
|
|
9 - Opsonization English.vtt
|
VTT
|
3.1 KB
|
|
|
9 - Opsonization.mp4
|
MP4
|
5.1 MB
|
|
|
90 - Sympathetic Ophthalmia Immune Privilege English.vtt
|
VTT
|
5.1 KB
|
|
|
90 - Sympathetic Ophthalmia Immune Privilege.mp4
|
MP4
|
10.1 MB
|
|
|
91 - Thymocyte Maturation in Thymus English.vtt
|
VTT
|
2.6 KB
|
|
|
91 - Thymocyte Maturation in Thymus.mp4
|
MP4
|
4.7 MB
|
|
|
92 - TST Mechanism Immune Response English.vtt
|
VTT
|
6.9 KB
|
|
|
92 - TST Mechanism Immune Response.mp4
|
MP4
|
14.2 MB
|
|
|
93 - Burn Classification English.vtt
|
VTT
|
3.7 KB
|
|
|
93 - Burn Classification.mp4
|
MP4
|
8.4 MB
|
|
|
94 - Burn Injuries English.vtt
|
VTT
|
3.8 KB
|
|
|
94 - Burn Injuries.mp4
|
MP4
|
9 MB
|
|
|
95 - Immune Aging English.vtt
|
VTT
|
3.1 KB
|
|
|
95 - Immune Aging.mp4
|
MP4
|
8.2 MB
|
|
|
96 - PAMPs and DAMPs English.vtt
|
VTT
|
3.8 KB
|
|
|
96 - PAMPs and DAMPs.mp4
|
MP4
|
7.1 MB
|
|
|
97 - Neutrophil Chemotaxis English.vtt
|
VTT
|
3.2 KB
|
|
|
97 - Neutrophil Chemotaxis.mp4
|
MP4
|
5.5 MB
|
|
|
98 - Serum Sickness Mechanism English.vtt
|
VTT
|
5.1 KB
|
|
|
98 - Serum Sickness Mechanism.mp4
|
MP4
|
10.3 MB
|
|
|
99 - TB Pathophysiology English.vtt
|
VTT
|
2.6 KB
|
|
|
99 - TB Pathophysiology.mp4
|
MP4
|
5.1 MB
|
|
|
Bonus Resources.txt
|
TXT
|
102.4 B
|
|
|
Get Bonus Downloads Here.url
|
URL
|
204.8 B
|
